Literature DB >> 10647952

Immune-mediated inner ear disease.

J H Stone1, H W Francis.   

Abstract

Immune-mediated inner ear disease (IMIED) is a syndrome that includes the subacute onset of sensorineural hearing loss, often accompanied by vertigo and tinnitus. This constellation of symptoms may occur as a primary disorder in which no other organ involvement is evident, or it may complicate certain systemic conditions, including Wegener's granulomatosis, Cogan's syndrome, polyarteritis nodosa, and systemic lupus erythematosus. The precise disease mechanisms remain undefined, largely because of the difficulty obtaining relevant tissue specimens in untreated patients. However, if treated promptly with aggressive immunosuppression, the devastating sequelae of IMIED may be avoided. In this article, we review the pathophysiology, clinical evaluation, diagnostic testing, and therapy of IMIED.

Entities:  

Mesh:

Year:  2000        PMID: 10647952     DOI: 10.1097/00002281-200001000-00006

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  12 in total

1.  [Bilateral deafness and unilateral facial nerve palsy as presenting features of Wegener's granulomatosis : a case report].

Authors:  S Bohne; S Koscielny; H P Burmeister; O Guntinas-Lichius; C Wittekindt
Journal:  HNO       Date:  2010-05       Impact factor: 1.284

Review 2.  Neuro-otological syndromes for the neurologist.

Authors:  J Overell; A Lindahl
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-12       Impact factor: 10.154

Review 3.  [Diagnosis, therapy and current research aspects of selected chronic inflammatory diseases with head and neck involvement].

Authors:  M Laudien; P Ambrosch; A Till; R Podschun; P Lamprecht
Journal:  Z Rheumatol       Date:  2008-09       Impact factor: 1.372

4.  Vestibular evoked myogenic potentials in Behcet's disease.

Authors:  Seyra Erbek; Selim S Erbek; Sema Yilmaz; Eftal Yucel; Levent N Ozluoglu
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-26       Impact factor: 2.503

Review 5.  Immunosuppressive therapy for autoimmune inner ear disease.

Authors:  Maria C Buniel; Katie Geelan-Hansen; Peter C Weber; Vincent K Tuohy
Journal:  Immunotherapy       Date:  2009-05       Impact factor: 4.196

6.  Temporal bone histopathology and immunoglobulin deposition in Sjogren's syndrome.

Authors:  Audrey P Calzada; Ashley E Balaker; Gail Ishiyama; Ivan A Lopez; Akira Ishiyama
Journal:  Otol Neurotol       Date:  2012-02       Impact factor: 2.311

7.  Association of retinal vasculitis (Eales' disease) and Meniere-like vestibulocochlear symptoms.

Authors:  Wolfgang Wagner; Astrid Fehrmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-08-24       Impact factor: 2.503

8.  Association between hepatitis B and hearing status.

Authors:  Mohamad Shayani Nasab
Journal:  Oman Med J       Date:  2012-09

9.  Cogan's syndrome: clinical evolution of deafness and vertigo in three patients.

Authors:  A Baumann; A Helbling; S Oertle; R Häusler; D Vibert
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-03-05       Impact factor: 2.503

10.  Cisplatin cytotoxicity of auditory cells requires secretions of proinflammatory cytokines via activation of ERK and NF-kappaB.

Authors:  Hongseob So; HyungJin Kim; Jeong-Han Lee; Channy Park; Yunha Kim; Eunsook Kim; Jin-Kyung Kim; Ki-Jung Yun; Kang-Min Lee; Haa-Yung Lee; Sung-Kyun Moon; David J Lim; Raekil Park
Journal:  J Assoc Res Otolaryngol       Date:  2007-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.